BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Gugliandolo A, Bramanti P, Mazzon E. Mesenchymal Stem Cells in Multiple Sclerosis: Recent Evidence from Pre-Clinical to Clinical Studies. Int J Mol Sci 2020;21:E8662. [PMID: 33212873 DOI: 10.3390/ijms21228662] [Cited by in Crossref: 21] [Cited by in F6Publishing: 24] [Article Influence: 10.5] [Reference Citation Analysis]
Number Citing Articles
1 Ahmed T. Neural stem cell engineering for the treatment of multiple sclerosis. Biomedical Engineering Advances 2022;4:100053. [DOI: 10.1016/j.bea.2022.100053] [Reference Citation Analysis]
2 Xun C, Deng H, Zhao J, Ge L, Hu Z. Mesenchymal stromal cell extracellular vesicles for multiple sclerosis in preclinical rodent models: A meta-analysis. Front Immunol 2022;13. [DOI: 10.3389/fimmu.2022.972247] [Reference Citation Analysis]
3 Borda M, Aquino JB, Mazzone GL. Cell-based experimental strategies for myelin repair in multiple sclerosis. J Neurosci Res 2022. [PMID: 36164729 DOI: 10.1002/jnr.25129] [Reference Citation Analysis]
4 Ojeda-hernández DD, Hernández-sapiéns MA, Reza-zaldívar EE, Canales-aguirre A, Matías-guiu JA, Matías-guiu J, Mateos-díaz JC, Gómez-pinedo U, Sancho-bielsa F. Exosomes and Biomaterials: In Search of a New Therapeutic Strategy for Multiple Sclerosis. Life 2022;12:1417. [DOI: 10.3390/life12091417] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
5 Cai S, Fan C, Xie L, Zhong H, Li A, Lv S, Liao M, Yang X, Su X, Wang Y, Wang H, Wang M, Huang P, Liu Y, Wang Y, Liu Y, Wang T, Zhong Y, Ma L. Single-cell RNA sequencing reveals the potential mechanism of heterogeneity of immunomodulatory properties of foreskin and umbilical cord mesenchymal stromal cells. Cell Biosci 2022;12:115. [PMID: 35869528 DOI: 10.1186/s13578-022-00848-w] [Reference Citation Analysis]
6 Carp DM, Liang Y. Universal or Personalized Mesenchymal Stem Cell Therapies: Impact of Age, Sex, and Biological Source. Cells 2022;11:2077. [DOI: 10.3390/cells11132077] [Reference Citation Analysis]
7 Bezukladova S, Genchi A, Panina-Bordignon P, Martino G. Promoting exogenous repair in multiple sclerosis: myelin regeneration. Curr Opin Neurol 2022;35:313-8. [PMID: 35674074 DOI: 10.1097/WCO.0000000000001062] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
8 Li H, Sun S, Yin Z, Cao S, Ji X, Duan X, Gao H, Wang M, Fang Q, Dong W, Zhang X, Gu Y, Xue Q. Depletion of B7-H4 from C3H10 T1/2 Mesenchymal Stem Cells Attenuates their Immunomodulatory Therapy in Experimental Autoimmune Encephalomyelitis Mice. Neurotox Res. [DOI: 10.1007/s12640-022-00509-3] [Reference Citation Analysis]
9 Allegretta C, D'Amico E, Manuti V, Avolio C, Conese M. Mesenchymal Stem Cell-Derived Extracellular Vesicles and Their Therapeutic Use in Central Nervous System Demyelinating Disorders. Int J Mol Sci 2022;23:3829. [PMID: 35409188 DOI: 10.3390/ijms23073829] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
10 Issa SS, Shaimardanova AA, Valiullin VV, Rizvanov AA, Solovyeva VV. Mesenchymal Stem Cell-Based Therapy for Lysosomal Storage Diseases and Other Neurodegenerative Disorders. Front Pharmacol 2022;13:859516. [PMID: 35308211 DOI: 10.3389/fphar.2022.859516] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
11 Zeng YS, Ding Y, Xu HY, Zeng X, Lai BQ, Li G, Ma YH. Electro-acupuncture and its combination with adult stem cell transplantation for spinal cord injury treatment: A summary of current laboratory findings and a review of literature. CNS Neurosci Ther 2022. [PMID: 35174644 DOI: 10.1111/cns.13813] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
12 Alvarez-viejo M, Haider KH. Mesenchymal Stem Cells. Handbook of Stem Cell Therapy 2022. [DOI: 10.1007/978-981-19-2655-6_6] [Reference Citation Analysis]
13 Alvarez-viejo M, Haider KH. Mesenchymal Stem Cells. Handbook of Stem Cell Therapy 2022. [DOI: 10.1007/978-981-16-6016-0_6-1] [Reference Citation Analysis]
14 Yarygin KN, Namestnikova DD, Sukhinich KK, Gubskiy IL, Majouga AG, Kholodenko IV. Cell Therapy of Stroke: Do the Intra-Arterially Transplanted Mesenchymal Stem Cells Cross the Blood-Brain Barrier? Cells 2021;10:2997. [PMID: 34831220 DOI: 10.3390/cells10112997] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
15 Matheakakis A, Batsali A, Papadaki HA, Pontikoglou CG. Therapeutic Implications of Mesenchymal Stromal Cells and Their Extracellular Vesicles in Autoimmune Diseases: From Biology to Clinical Applications. Int J Mol Sci 2021;22:10132. [PMID: 34576296 DOI: 10.3390/ijms221810132] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
16 Ślusarz R, Olkiewicz J, Bonek R, Filipska K, Biercewicz M, Wiśniewski A. The Impact of Motor Disability and the Level of Fatigue on Adherence to Therapeutic Recommendations in Patients with Multiple Sclerosis Treated with Immunomodulation. Int J Med Sci 2021;18:3609-14. [PMID: 34522188 DOI: 10.7150/ijms.61964] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
17 He J, Huang Y, Liu J, Lan Z, Tang X, Hu Z. The Efficacy of Mesenchymal Stem Cell Therapies in Rodent Models of Multiple Sclerosis: An Updated Systematic Review and Meta-Analysis. Front Immunol 2021;12:711362. [PMID: 34512632 DOI: 10.3389/fimmu.2021.711362] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
18 Wen J, Moloney EB, Canning A, Donohoe E, Ritter T, Wang J, Xiang D, Wu J, Li Y. Synthesized nanoparticles, biomimetic nanoparticles and extracellular vesicles for treatment of autoimmune disease: Comparison and prospect. Pharmacol Res 2021;172:105833. [PMID: 34418563 DOI: 10.1016/j.phrs.2021.105833] [Reference Citation Analysis]
19 Abdelgawad M, Bakry NS, Farghali AA, Abdel-Latif A, Lotfy A. Mesenchymal stem cell-based therapy and exosomes in COVID-19: current trends and prospects. Stem Cell Res Ther 2021;12:469. [PMID: 34419143 DOI: 10.1186/s13287-021-02542-z] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 9.0] [Reference Citation Analysis]
20 Gutiérrez-Fernández M, de la Cuesta F, Tallón A, Cuesta I, Fernández-Fournier M, Laso-García F, Gómez-de Frutos MC, Díez-Tejedor E, Otero-Ortega L. Potential Roles of Extracellular Vesicles as Biomarkers and a Novel Treatment Approach in Multiple Sclerosis. Int J Mol Sci 2021;22:9011. [PMID: 34445717 DOI: 10.3390/ijms22169011] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
21 Smith JA, Nicaise AM, Ionescu RB, Hamel R, Peruzzotti-Jametti L, Pluchino S. Stem Cell Therapies for Progressive Multiple Sclerosis. Front Cell Dev Biol 2021;9:696434. [PMID: 34307372 DOI: 10.3389/fcell.2021.696434] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 10.0] [Reference Citation Analysis]
22 Mallis P, Michalopoulos E, Chatzistamatiou T, Giokas CS. Interplay between mesenchymal stromal cells and immune system: clinical applications in immune-related diseases. Explor Immunol. [DOI: 10.37349/ei.2021.00010] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
23 Racchetti G, Meldolesi J. Extracellular Vesicles of Mesenchymal Stem Cells: Therapeutic Properties Discovered with Extraordinary Success. Biomedicines 2021;9:667. [PMID: 34200818 DOI: 10.3390/biomedicines9060667] [Cited by in Crossref: 20] [Cited by in F6Publishing: 21] [Article Influence: 20.0] [Reference Citation Analysis]